Eton Pharmaceuticals, Inc. (ETON) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Eton Pharmaceuticals, Inc. (ETON) Bundle
Gain insights into your Eton Pharmaceuticals, Inc. (ETON) valuation analysis using our state-of-the-art DCF Calculator! This Excel template comes preloaded with real ETON data, enabling you to adjust forecasts and assumptions for an accurate calculation of Eton Pharmaceuticals' intrinsic value.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.0 | .0 | 21.8 | 21.3 | 31.6 | 35.6 | 40.1 | 45.1 | 50.8 | 57.2 |
| Revenue Growth, % | 0 | -95.93 | 55879.49 | -2.66 | 48.9 | 12.58 | 12.58 | 12.58 | 12.58 | 12.58 |
| EBITDA | -18.2 | -26.5 | -1.1 | -6.5 | -.3 | -16.9 | -19.0 | -21.4 | -24.0 | -27.1 |
| EBITDA, % | -1893.01 | -67846.15 | -5.13 | -30.52 | -0.91966 | -47.32 | -47.32 | -47.32 | -47.32 | -47.32 |
| Depreciation | .4 | .7 | .4 | 1.8 | .9 | 11.4 | 12.8 | 14.4 | 16.2 | 18.3 |
| Depreciation, % | 46.61 | 1669.23 | 2.05 | 8.31 | 2.85 | 31.96 | 31.96 | 31.96 | 31.96 | 31.96 |
| EBIT | -18.6 | -27.1 | -1.6 | -8.3 | -1.2 | -17.8 | -20.0 | -22.6 | -25.4 | -28.6 |
| EBIT, % | -1939.62 | -69515.38 | -7.18 | -38.83 | -3.77 | -49.96 | -49.96 | -49.96 | -49.96 | -49.96 |
| Total Cash | 12.1 | 21.3 | 14.4 | 16.3 | 21.4 | 29.2 | 32.9 | 37.0 | 41.7 | 46.9 |
| Total Cash, percent | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .5 | .0 | 5.5 | 1.9 | 3.4 | 13.8 | 15.5 | 17.5 | 19.7 | 22.2 |
| Account Receivables, % | 49.32 | 123.08 | 25.06 | 8.71 | 10.78 | 38.78 | 38.78 | 38.78 | 38.78 | 38.78 |
| Inventories | .4 | 1.2 | .6 | .6 | .9 | 10.5 | 11.8 | 13.3 | 15.0 | 16.9 |
| Inventories, % | 39.62 | 3184.62 | 2.52 | 2.62 | 2.88 | 29.53 | 29.53 | 29.53 | 29.53 | 29.53 |
| Accounts Payable | .6 | 2.3 | 1.8 | 1.8 | 1.8 | 13.0 | 14.6 | 16.5 | 18.5 | 20.9 |
| Accounts Payable, % | 59.96 | 6010.26 | 8.13 | 8.31 | 5.84 | 36.45 | 36.45 | 36.45 | 36.45 | 36.45 |
| Capital Expenditure | -1.8 | -.1 | -3.3 | -2.8 | -.8 | -16.4 | -18.5 | -20.8 | -23.4 | -26.4 |
| Capital Expenditure, % | -192.49 | -128.21 | -14.93 | -13.12 | -2.45 | -46.1 | -46.1 | -46.1 | -46.1 | -46.1 |
| Tax Rate, % | -35.85 | -35.85 | -35.85 | -35.85 | -35.85 | -35.85 | -35.85 | -35.85 | -35.85 | -35.85 |
| EBITAT | -18.3 | -27.9 | -2.4 | -8.9 | -1.6 | -17.7 | -20.0 | -22.5 | -25.3 | -28.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -20.0 | -26.0 | -10.5 | -6.4 | -3.3 | -31.6 | -27.1 | -30.5 | -34.3 | -38.6 |
| WACC, % | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -120.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -39 | |||||||||
| Terminal Value | -475 | |||||||||
| Present Terminal Value | -291 | |||||||||
| Enterprise Value | -412 | |||||||||
| Net Debt | -16 | |||||||||
| Equity Value | -396 | |||||||||
| Diluted Shares Outstanding, MM | 26 | |||||||||
| Equity Value Per Share | -15.43 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ETON financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the highlighted cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Eton’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Eton Pharmaceuticals, Inc. (ETON).
- WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to Eton Pharmaceuticals, Inc. (ETON).
- Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates relevant to Eton Pharmaceuticals, Inc. (ETON).
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for Eton Pharmaceuticals, Inc. (ETON).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of Eton Pharmaceuticals, Inc. (ETON).
How It Works
- Step 1: Download the prebuilt Excel template featuring Eton Pharmaceuticals, Inc.'s (ETON) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Immediately see the recalculated results, including Eton Pharmaceuticals, Inc.'s (ETON) intrinsic value.
- Step 5: Utilize the outputs to make informed investment decisions or create detailed reports.
Why Choose This Calculator for Eton Pharmaceuticals, Inc. (ETON)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
- Accurate Data: Eton's historical and projected financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth calculation process.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Eton Pharmaceuticals stock (ETON).
- Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Eton Pharmaceuticals (ETON).
- Consultants: Deliver professional valuation insights on Eton Pharmaceuticals (ETON) to clients quickly and accurately.
- Business Owners: Understand how pharmaceutical companies like Eton Pharmaceuticals (ETON) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Eton Pharmaceuticals (ETON).
What the Template Contains
- Pre-Filled Data: Includes Eton Pharmaceuticals' historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Eton Pharmaceuticals' profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.